Table 2.
Comparison of study population and overall T1D clinic adolescent population
| Variable | Study population | T1D clinic population (n=386) |
| (n=215) | ||
| Age (years) | ||
| Median (IQR) | 14.9 (13.9, 15.9) | 15.0 (14.0, 17.0) |
| Mean (SD) | 15.0 (1.2) | 15.2 (1.4) |
| Missing | 0 | 0 |
| Gender, n (%) | ||
| Male | 118 (54.9) | 207 (53.6%) |
| Female | 97 (45.1) | 179 (46.4%) |
| Missing | 0 | 0 |
| Duration of diabetes (years) | ||
| Median (IQR) | 5.8 (2.9, 8.9) | 5.8 (2.8, 9.3) |
| Mean (SD) | 6.1 (3.9) | 6.3 (4.2) |
| Missing | 0 | 9 |
| HbA1c (%) | ||
| Median (IQR) | 7.9 (7.1, 8.8) | 7.9 (7.0, 9.0) |
| Mean (SD) | 8.1 (1.6) | 8.2 (1.7) |
| Missing | 0 | 18 |
| Insulin regimen, n (%) | ||
| Injection | 105 (48.8) | 206 (53.5) |
| Pump | 110 (51.2) | 179 (46.5) |
| Missing | 0 | 1 |
| CGM, n (%) | 112 (52.1) | 210 (59.2) |
| Missing | 0 | 31 |
Characteristics of study participants and a cross-sectional census of the adolescent T1D clinic population.
CGM, continuous glucose monitoring; HbA1c, haemoglobin A1c.